Medicsight's colonography analysis software receives Brazilian
regulatory approval
3 September 2008
Medicsight PLC, the London-based developer of computer-aided
detection (CAD) and medical image analysis software has received
approval from the Brazilian regulatory agency, Agencia Nacional de
Vigilancia Sanitaria (ANVISA), for its ColonCAD software.
Medicsight’s ColonCAD computer-aided detection technology aims to
assist radiologists in the detection of colorectal neoplasia (polyps) by
automatically highlighting suspicious areas on CT colonography scan
images. The software may also help radiologists detect potentially
malignant tumours at an early stage when treatment is most likely to be
successful.
David Sumner, Chief Executive of Medicsight, commented: “This is
another important milestone for Medicsight and our partners as we
commercialise our technology globally. This regulatory approval in the
dynamic Latin American market is another approval in a high-growth BRIC
market, following on from the Chinese State Food and Drug Administration
approval announced in April.”
Dr Stuart Taylor of University College Hospital, London, a principal
investigator for Medicsight, commented: “The approval of Medicsight’s
ColonCAD software is great news for patients. It will also be a bonus
for radiologists, whose workload is growing rapidly, both due to the
rising prevalence of colorectal cancer and the advances in imaging
technology which have led to a substantial increase in the amount of
image data that must be reviewed for each patient scan.
"Medicsight’s technology can help to ease this burden, potentially
reducing human error and also providing a valuable tool, especially for
less experienced readers, to interpret these complex scans.
“Medicsight’s CAD software has been validated against one of the
world’s largest and most population diverse proprietary databases of
verified CT scan data, making the software applicable to patients of
many different nationalities.”